

[ Mon, Sep 16th 2024
] - WOPRAI
[ Mon, Sep 16th 2024
] - WOPRAI

[ Tue, Aug 13th 2024
] - WOPRAI

[ Fri, Aug 09th 2024
] - WOPRAI

[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI

[ Fri, Jun 14th 2024
] - WOPRAI

[ Thu, Jun 13th 2024
] - WOPRAI

[ Wed, May 15th 2024
] - WOPRAI

[ Tue, May 07th 2024
] - WOPRAI

[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI

[ Mon, Apr 01st 2024
] - WOPRAI

[ Thu, Mar 21st 2024
] - WOPRAI

[ Fri, Mar 15th 2024
] - WOPRAI

[ Mon, Mar 04th 2024
] - WOPRAI

[ Wed, Feb 28th 2024
] - WOPRAI
[ Wed, Feb 28th 2024
] - WOPRAI

[ Fri, Feb 23rd 2024
] - WOPRAI

[ Mon, Feb 12th 2024
] - WOPRAI

[ Fri, Nov 10th 2023
] - WOPRAI

[ Fri, Nov 03rd 2023
] - WOPRAI

[ Tue, Aug 01st 2023
] - WOPRAI

[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI


[ Mon, Jan 30th 2023
] - WOPRAI

[ Thu, Jan 05th 2023
] - WOPRAI

[ Tue, Nov 01st 2022
] - WOPRAI

[ Fri, Jun 24th 2022
] - WOPRAI

[ Mon, Apr 11th 2022
] - WOPRAI


[ Thu, Feb 03rd 2022
] - WOPRAI

[ Mon, Jul 12th 2021
] - WOPRAI

[ Fri, Feb 26th 2021
] - WOPRAI

[ Mon, Feb 22nd 2021
] - WOPRAI

[ Wed, Mar 28th 2018
] - WOPRAI
Etzer Darout Reiterated (ACRV) at Buy with Increased Target to $28 on, Sep 16th, 2024
Etzer Darout of BMO Capital, Reiterated "Acrivon Therapeutics, Inc." (ACRV) at Buy with Increased Target from $25 to $28 on, Sep 16th, 2024.
Etzer, nor any peers, have made any analyst calls on ACRV in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30